Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary-Reference-Cited by-同舟云学术

Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary

Published:2016-04 Issue:4 Volume:12 Page:510-515
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Rabinovici Gil D.¹,Karlawish Jason²,Knopman David³,Snyder Heather M.⁴,Sperling Reisa⁵,Carrillo Maria C.⁴

Affiliation:

1. Department of Neurology University of California, San Francisco San Francisco CA USA

2. Departments of Medicine, Medical Ethics and Health Policy, and Neurology University of Pennsylvania Philadelphia PA USA

3. Department of Neurology Mayo Clinic Rochester MN USA

4. Medical and Scientific Relations Alzheimer's Association Chicago IL USA

5. Department of Neurology Harvard Medical School Boston MA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2016.03.002

Reference20 articles.

1. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

2. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

3. Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy

4. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

5. Absence of Pittsburgh Compound B Detection of Cerebral Amyloid β in a Patient With Clinical, Cognitive, and Cerebrospinal Fluid Markers of Alzheimer Disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights;Brain Research;2024-07

2. Here's How Coverage for Amyloid PET Is Changing;Neurology Today;2023-12-07

3. Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression;Materials Today Bio;2023-08

4. Nutritional Interventions for the Prevention of Cognitive Decline in Patients with Mild Cognitive Impairment and Alzheimer’s Disease: Protocol for A Network Meta-Analysis of Randomized Control Trials (Preprint);JMIR Research Protocols;2023-03-11

5. Nutritional Interventions for the Prevention of Cognitive Function in Patients with Mild Cognitive Impairment and Alzheimer’s Disease: A Network Meta-Analysis of Randomized Control Trials (Preprint);2023-03-11